htrB of Haemophilus influenzae: determination of biochemical activity and effects on virulence and lipooligosaccharide toxicity

Abstract

The htrB mutant of Haemophilus influenzae (strain B29) has been shown to lack secondary (non-hydroxylated) acyl groups in its lipid A. We have determined through in vitro biochemical assays that the HtrB protein acts as a specific acyltransferase in the late stages of lipid A biosynthesis and that the preferred acyl group donor is myristoyl-acyl carrier protein. Under the conditions employed, the Escherichia coli precursor, Kdo₂-lipid IV_A, functions as a myristate acceptor. Introduction of the Haemophilus htrB gene into an E. coli mutant lacking htrB complements the biochemical and physiological defects associated with the E. coli htrB mutation.

Tumor necrosis factor α (TNFα) assays using murine and human macrophage cells indicated that nontypeable H. influenzae (NtHi) strain 2019 and H. influenzae type b strain A2 elicit levels of expression of TNFα that are 30-40 times greater than levels induced by the isogenic htrB mutants (B29 and A2B29). Studies using cell-free LOS indicated that the LOS from wild type strain 2019 elicits levels of TNFα expression that are 6-8-fold higher than those of B29. In situ hybridization studies of a primary human bronchial epithelial cell line demonstrated a greater increase of TNFα message produced in the presence of 2019 LOS than in the presence of B29 LOS. TNFα levels of the cell supernatant of cells stimulated with 2019 LOS were found to be 7-8-fold higher than levels in B29 stimulated supernatants. Using the Limulus amoebocyte lysate for assessment of endotoxic activity, we found that wild type LOS was 8-fold higher in endotoxic activity compared with the mutant LOS. In virulence assays using intraperitoneal inoculation of infant rats, the htrB isogenic strain caused bacteremia at 50% the frequency of the wild type strain. In intranasal inoculation studies, the htrB mutant strain was unable to cause bacteremia whereas the wild type b parent produced bacteremia in 40-60% of the animals. These findings suggest that the htrB gene of H. influenzae is important for virulence and that host TNFα expression is attenuated in response to htrB mutant strains.

Get full access to this article

View all access options for this article.

References

Zwahlen A. , Rubin L.G. , Moxon E.R. Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats. Microb Pathogen 1986; 1: 465-473.

Kimura A. , Hansen E.J. Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence. Infect Immun 1986; 51: 69-79.

Kimura A. , Patrick C.C. , Miller E.E. , Cope L.D. , McCracken G.H. , Hansen E.J. Haemophilus influenzae type b lipopolysaccharide: stability of expression and association with virulence. Infect Immun 1987; 55: 1979-1986.

Gibson B.W. , Melaugh W. , Phillips N.J. , Apicella M.A. , Campagnari A.A. , Griffiss J.M. Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry. J Bacteriol 1993; 175: 2702-2712.

Lee N-G. , Sunshine M.G. , Apicella M.A. Molecular cloning and characterization of the nontypeable Haemophilus influenzae 2019 rfaE gene required for lipopolysaccharide biosynthesis. Infect Immun 1995; 63: 818-824.

Lee N-G. , Sunshine M.G. , Engstrom J.J. , Gibson B.W. , Apicella M.A. Mutation of the htrB locus of Haemophilus influenzae nontypeable strain 2019 is associated with modifications of lipid A and phosphorylation of the lipo-oligosaccharide . J Biol Chem 1995; 270:27151-27159.

Clementz T. , Bednarski J.J. , Raetz C.R.H. Function of the htrB high temperature requirement of Escherichia coli in the acylation of lipid A: HtrB catalyzed incorporation of laurate. J Biol Chem 1996; 271: 12095-12102.

Raetz C.R.H. Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction. J Bacteriol 1993; 175: 5745-5753.

Stephens D.S. , Farley M.M. Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae. Rev Infect Dis 1991; 13: 22-33.

10.

Tanamoto K-I. Predominant role of the substituents on the hydroxyl groups of 3-hydroxy fatty acids of non-reducing glucosamine in lipid A for the endotoxic and antagonistic activity. FEBS Lett 1994; 351: 325-329.

11.

Golenbock D.T. , Hampton R.Y. , Qureshi N. , Takayama K. , Raetz C.R.H. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991; 266: 19490-19498.

12.

Galanos D. , Luderitz O. , Rietschel E.T. , Westphal O. A new method for the extraction of R lipopolysaccharide. Eur J Biochem 1969; 9: 245-249.

13.

Espevik T. , Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986; 95: 99-105.

14.

Smith A.L. , Averill D.R. , Mariano J. , Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun 1973; 8: 278-290.

15.

Moxon E.R. , Smith A.L. , Averill D.R. Jr., Smith D.H. Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis 1974; 129: 154-162.

16.

White K.A. , Kaltashov I.A. , Cotter R.J. , Raetz C. R.H. A monofunctional 3-deoxy-D-manno-octulosonic acid (Kdo) transferase and a Kdo kinase in extracts of Haemophilus influenzae. J Biol Chem 1997; In press.

17.

Raetz C.R.H. Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles . In: Neidhardt F.C.E.LC. , Curtis R.I. , Ingrahm J.L. et al. Eds Escherichia coli and Salmonella: Cellular and Molecular Biology, vol. 1, 2nd edn. Washington DC: ASM Press, 1996; 1035-1063.

18.

Raetz C.R.H. Biochemistry of endotoxins. Annu Rev Biochem 1990; 59: 129-170.

19.

Morrison D.C. , Ryan J.L. Endotoxins and disease mechanisms. Annu Rev Med 1987; 38: 417-432.

20.

Pohlman TH , Munford R.S. , Harlan J.M. Deacylated hpopoly-saccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro. J Exp Med 1987; 165: 1393-1402.

21.

Loppnow H. , Libby P. , Freudenberg M. , Krauss J.H. , Wekesser J. , Mayer H. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun 1990; 58: 3743-3750.

22.

Christ W.H. , Asano O. , Robidoux A.L. et al. E5531, a pure endotoxin antagonist of extraordinary potency: chemistry and biology. Science 1995; 265: 80-83.

23.

Bunnell E. , Neumann A. , Lynn M. et al. E5531, an endotoxin antagonist, blocks the hyperdynamic and depressant cardiovascular effects of endotoxin in healthy subjects. Crit Care Med Suppl 1995; 23: A151.

24.

Kaplan S.L. , Hawkins E.P. , Inzana T.J. , Patrick C.C. , Mason E. OJr. Contribution of Haemophilus influenzae type b lipopolysaccharide to pathogenesis of infection. Microb Pathogen 1988; 5: 55-62.

25.

Somerville Jr J.E. , Cassiano L. , Bainbridge B. , Cunningham M.D. , Darveau R.P. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J Clin Invest 1996; 97: 359-365.

26.

Clementz T. , Zhou Z. , Raetz C.R.H. Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB. J Biol Chem 1997; 272: 10353-10360.

27.

Anderson P. , Johnston R.B. , Smith D.H. Human serum activities against Haemophilus influenzae, type b. J Clin Invest 1972; 51: 31-38.

28.

Karow M. , Fayet O. , Cegielska A. , Ziegelhoffer T. , Georgopoulos C. Isolation and characterization of the Escherichia coli htrB gene, whose product is essential for bacterial viability above 33°C in rich media. J Bacteriol 1991; 173: 741-750.